- Home
- DSY vs GNTA Comparison
DSY vs GNTA Comparison
Compare DSY & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- GNTA
- Stock Information
- Founded
- DSY 2020
- GNTA 2014
- Country
- DSY China
- GNTA Italy
- Employees
- DSY N/A
- GNTA N/A
- Industry
- DSY
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSY
- GNTA Health Care
- Exchange
- DSY Nasdaq
- GNTA Nasdaq
- Market Cap
- DSY 72.0M
- GNTA 81.2M
- IPO Year
- DSY N/A
- GNTA 2021
- Fundamental
- Price
- DSY $1.41
- GNTA $3.93
- Analyst Decision
- DSY
- GNTA Strong Buy
- Analyst Count
- DSY 0
- GNTA 1
- Target Price
- DSY N/A
- GNTA $25.00
- AVG Volume (30 Days)
- DSY 11.9K
- GNTA 28.5K
- Earning Date
- DSY 02-10-2025
- GNTA 01-01-0001
- Dividend Yield
- DSY N/A
- GNTA N/A
- EPS Growth
- DSY 120.37
- GNTA N/A
- EPS
- DSY 0.01
- GNTA N/A
- Revenue
- DSY $7,323,356.00
- GNTA N/A
- Revenue This Year
- DSY N/A
- GNTA N/A
- Revenue Next Year
- DSY N/A
- GNTA N/A
- P/E Ratio
- DSY $114.44
- GNTA N/A
- Revenue Growth
- DSY 16.37
- GNTA N/A
- 52 Week Low
- DSY $0.75
- GNTA $2.74
- 52 Week High
- DSY $6.98
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- DSY 54.87
- GNTA 56.78
- Support Level
- DSY $1.37
- GNTA $2.74
- Resistance Level
- DSY $1.46
- GNTA $3.39
- Average True Range (ATR)
- DSY 0.07
- GNTA 0.28
- MACD
- DSY 0.02
- GNTA 0.05
- Stochastic Oscillator
- DSY 73.91
- GNTA 94.17
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.